Loading
Latest filing published 17 Mar 2026 for Oncopeptides AB, €2,041.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Henrik Bergentoft appears in our data through filings on Oncopeptides AB shares, published by Finansinspektionen. Over a trading history stretching from 10 November 2023 to 16 March 2026, the count stands at 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €6,002, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 17 March 2026, the filings show a transaction worth €2,041 in Oncopeptides AB. The latest purchase dates back some time: it was published 1,078 days ago, on 12 November 2023. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations